News
Lewy body disease is a stealthy and relentless brain disorder that affects memory, movement, and core body functions. It ...
"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.
11d
Kyodo News on MSNFinal phase of trial for Parkinson's drug to treat Alzheimer's begins in JapanThe final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...
New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...
A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ ...
Two new drugs targeting early-stage Alzheimer’s disease are expected to be put into clinical use as soon as Thursday next ...
Kyoto, June 3 (Jiji Press)--A Japanese team said Tuesday that it has started a final-stage clinical trial to administer to ...
This is a big step forward. If these findings are confirmed in larger studies, doctors could start using brain network scans ...
Professor Himanshu Rai gets us started on the concepts of brains, funding, and breakthroughs in Japan’s master plan for ...
9d
News-Medical.Net on MSNIntegrating discoveries with translational science to transform Alzheimer's careAt the 12th annual Helen and Robert Appel Alzheimer's Disease Research Institute Symposium, scientists and clinicians shared ...
A US study shows that many research participants don’t want to know their risks of getting Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results